322 related articles for article (PubMed ID: 29661670)
1. [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT].
Morros R; Vedia C; Giner-Soriano M; Casellas A; Amado E; Baena JM;
Aten Primaria; 2019; 51(6):333-340. PubMed ID: 29661670
[TBL] [Abstract][Full Text] [Related]
2. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
JAMA; 2018 Oct; 320(15):1548-1559. PubMed ID: 30326124
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
Tashkin DP; Strange C
Int J Chron Obstruct Pulmon Dis; 2018; 13():2587-2601. PubMed ID: 30214177
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Spencer S; Evans DJ; Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
[TBL] [Abstract][Full Text] [Related]
6. Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.
DiSantostefano RL; Sampson T; Le HV; Hinds D; Davis KJ; Bakerly ND
PLoS One; 2014; 9(5):e97149. PubMed ID: 24878543
[TBL] [Abstract][Full Text] [Related]
7. Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety.
Suissa S; Dell'Aniello S; Ernst P
Int J Chron Obstruct Pulmon Dis; 2022; 17():1975-1986. PubMed ID: 36065315
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
Suissa S; Dell'Aniello S; Ernst P
Lancet Respir Med; 2018 Nov; 6(11):855-862. PubMed ID: 30343028
[TBL] [Abstract][Full Text] [Related]
9. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.
Puhan MA; Bachmann LM; Kleijnen J; Ter Riet G; Kessels AG
BMC Med; 2009 Jan; 7():2. PubMed ID: 19144173
[TBL] [Abstract][Full Text] [Related]
10. Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA.
Stanford RH; Parker ED; Reinsch TK; Buikema AR; Blauer-Peterson C
Respir Med; 2019 Apr; 150():1-7. PubMed ID: 30961933
[TBL] [Abstract][Full Text] [Related]
11. Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.
Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Anzueto A; Alagappan VK; Siddiqui S; Rekeda L; Miller CJ; Zetterstrand S; Reisner C; Rennard SI
Am J Respir Crit Care Med; 2016 Sep; 194(5):559-67. PubMed ID: 27585384
[TBL] [Abstract][Full Text] [Related]
12. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
13. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
Di Martino M; Agabiti N; Cascini S; Kirchmayer U; Bauleo L; Fusco D; Belleudi V; Pinnarelli L; Voci C; Patorno E; Pistelli R; Davoli M;
COPD; 2016 Jun; 13(3):293-302. PubMed ID: 26514912
[TBL] [Abstract][Full Text] [Related]
14. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
Pavord ID; Lettis S; Anzueto A; Barnes N
Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
[TBL] [Abstract][Full Text] [Related]
15. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
[TBL] [Abstract][Full Text] [Related]
17. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
18. Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.
Cheng SL; Su KC; Wang HC; Perng DW; Yang PC
Drug Des Devel Ther; 2014; 8():601-7. PubMed ID: 24920884
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids in COPD: friend or foe?
Agusti A; Fabbri LM; Singh D; Vestbo J; Celli B; Franssen FME; Rabe KF; Papi A
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30190269
[TBL] [Abstract][Full Text] [Related]
20. Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study.
Suissa S; Dell'Aniello S; Ernst P
Chest; 2017 Jan; 151(1):60-67. PubMed ID: 27554300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
